|
ATP7A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.222100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.952300E-02 |
| Normal-vs-Stage2 |
4.087600E-02 |
| Normal-vs-Stage3 |
4.627700E-04 |
| Normal-vs-Stage4 |
7.63780000000436E-05 |
| Stage1-vs-Stage2 |
8.189800E-01 |
| Stage1-vs-Stage3 |
7.905800E-02 |
| Stage1-vs-Stage4 |
8.380300E-03 |
| Stage2-vs-Stage3 |
2.877200E-01 |
| Stage2-vs-Stage4 |
8.121700E-02 |
| Stage3-vs-Stage4 |
3.867400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.275000E-03 |
| Normal-vs-AfricanAmerican |
7.113400E-01 |
| Normal-vs-Asian |
3.742600E-03 |
| Caucasian-vs-AfricanAmerican |
8.334300E-02 |
| Caucasian-vs-Asian |
5.958800E-01 |
| AfricanAmerican-vs-Asian |
5.991700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.595800E-04 |
| Normal-vs-Female |
1.178220E-02 |
| Male-vs-Female |
1.027970E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.476400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.758620E-03 |
| Normal-vs-Age(61-80Yrs) |
2.458300E-03 |
| Normal-vs-Age(81-100Yrs) |
2.997800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.254630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.712440E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.482200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.314400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.720200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.799800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.181600E-04 |
| Classical-VS-Follicular |
8.279000E-01 |
| Classical-VS-Other |
3.843600E-01 |
| Classical-VS-Normal |
1.996040E-02 |
| Tall-VS-Follicular |
8.359400E-03 |
| Tall-VS-Other |
5.516600E-01 |
| Tall-VS-Normal |
4.48020000000104E-05 |
| Follicular-VS-Other |
4.718800E-01 |
| Follicular-VS-Normal |
4.050000E-02 |
| Other-VS-Normal |
6.804300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.955900E-03 |
| Normal-vs-N1 |
3.551900E-04 |
| N0-vs-N1 |
1.696430E-01 |
|
|
